Webinar 145: The Biopharmaceuticals sector in Japan

How can I access the Japanese market as a novel biopharmaceutical product's owner?

Japan includes a huge market for biopharmaceutical products which is open for innovative products and services, also those from abroad. Current trends are in immunotherapeuticals, cell-based products and genomic medicine. Japanese regulations favour innovative products and services and thus may offer an opportunity for fast-track market access. In view of specific rules and regulations, however, it may be advantageous for European SMEs to team up with Japanese or international marketing authorisation holders (MAHs).

The webinar is targeted to EU companies seeking to export their innovative biopharmaceutical products or services to Japan .

Registration deadline: 16/10/2019

In 40 minutes from your desk, you will discover how to:

• Position your product or service in the existing Japanese biopharmaceutical market
• Assess if you qualify for an innovative product or service to earn "forerunner benefits"
• Approach the Japanese market through appropriate marketing authorization holders (MAHs)
• Meet MAHs and other relevant stakeholders

Programme:

• Introduction
• Expert’s presentation
• Q&A Session
• Conclusion

Speaker: Rolf Schmid - Bio4Business 
Moderator: Gwenael Beauvais - Business Support Coordinator, EU-Japan Centre for Industrial Cooperation
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office

After Event Information